Single Ascending Dose Study (SAD) iv Formulation

NCT00688831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AZD1305
DRUG: Placebo

Sponsor

AstraZeneca